These resources include: A CISP Checklist Implementing Revised List Athlete and Athlete Support Personnel (ASP) Factsheet on Glucocorticoid injections Medical Professionals Factsheet on Glucocorticoid injections Athlete and ASP Guide to the 2022 List 2022 List Webinar In order to further assist stakeholders in their understanding and implementation of the 2022 List, WADA hosted a webinar in November 2021
Other intranasal preparations being explored in Parkinsons include dopamine, one using gene therapy, a vitamin E loaded naringenin, stem cells, glial cell-derived neurotrophic factor (GDNF), carnosine, BDNF, intranasal insulin, rotigotine, and estradiol
Retatrutide is an investigational triple-agonist peptide designed to activate: GLP-1 (Glucagon-Like Peptide-1) receptors GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors Glucagon receptors By targeting all three pathways, retatrutide addresses appetite regulation, insulin resistance, energy expenditure, and fat metabolism together rather than focusing on appetite suppression alone
Laboratory studies show GHK-Cu treatment results in improved hair shaft diameter, enhanced cuticle structure regularity, increased cortical density, and superior overall fiber integrity, translating into hair that appears thicker, stronger, and more resistant to breakage in experimental models
Made in USA Directly Imported All Products